Browse
Submit Data
Databases
API
Help

Dataset Information

364 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human Transcription Factors LC-MSMS

ABSTRACT: How transcription factors (TFs), the ultimate targets and executors of cellular signalling pathways, are regulated via protein-protein interactions remains elusive. To systematically investigate the regulations and functions of human transcription factors, we performed proteomics studies of soluble and chromatin-associated complexes of 56 TFs in HEK293T cells, using tandem-affinity-purification followed by mass spectrometry (TAP/MS). We performed 214 purifications and identified 2,156 high-confident protein-protein interactions.

INSTRUMENT(S): LTQ

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Hek-293t Cell, Early Embryonic Cell

DISEASE(S): Disease Free

SUBMITTER: Xu Li

LAB HEAD: Junjie Chen

PROVIDER: PXD001383 | Pride | 2015-04-07

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	21877.RAW	Raw
	21877.pride.mgf.gz	Mgf
	21877.pride.mztab.gz	Mztab
	21877.xml.gz	Xml
	21878.RAW	Raw

Items per page:

1 - 5 of 856

Publications

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

Li Xu X Wang Wenqi W Wang Jiadong J Malovannaya Anna A Xi Yuanxin Y Li Wei W Guerra Rudy R Hawke David H DH Qin Jun J Chen Junjie J

Molecular systems biology 20150121 1

The current knowledge on how transcription factors (TFs), the ultimate targets and executors of cellular signalling pathways, are regulated by protein-protein interactions remains limited. Here, we performed proteomics analyses of soluble and chromatin-associated complexes of 56 TFs, including the targets of many signalling pathways involved in development and cancer, and 37 members of the Forkhead box (FOX) TF family. Using tandem affinity purification followed by mass spectrometry (TAP/MS), we ...[more]

PMID: 25609649

Similar Datasets

Interactome analysis of human phospholipase D and phosphatidic acid-associated protein network

Project description:Using a systematic proteomic approach, we define the protein-protein interaction network for PLD superfamily and phosphatidic acid in human cells and reveal diverse cellular signaling events involved for this key protein family and lipid.

2022-01-16 | PXD029183 | Pride

Human WW-domain containing proteins TAP-LC-MSMS

Project description:To systematically investigate the regulations and functions of human WW-domain containing proteins, we conducted a proteomic analysis of 26 full-length WW-domain containing proteins and 17 WW-domains only, and identified their associated protein complexes in human HEK293T cells using tandem affinity purifications followed by LC-MSMS.

2019-12-02 | PXD004649 | Pride

Human MAP4K proteins TAP-LC-MSMS

Project description:Using a systematic proteomic approach, we define the protein-protein interaction network for MAP4K family kinases in human cells and reveal diverse cellular signaling events involving this key kinase family. We conducted a proteomic analysis of 7 MAP4K proteins, each with two biological replicates , and identified their associated protein complexes in human HEK293T cells using tandem affinity purifications followed by LC-MSMS.

2020-06-29 | PXD016931 | Pride

Human Tankyrases TAP-LC-MSMS - Proteomic Analysis of the Human Tankyrase Protein Interaction Network Reveals Its Role in Pexophagy

Project description:Tankyrase 1 (TNKS1) and tankyrase 2 (TNKS2) belong to the poly(ADP-ribose) polymerase (PARP) family of proteins, which use NAD+ to modify substrate proteins with ADP-ribose modifications. Tankyrases are implicated involving in multiple cellular functions, including the telomere length control, Wnt/b-catenin pathway regulation, glucose uptake and cell cycle regulation. Emerging evidences reveal the pathological relevance of tankyrase in diseases and propose these two key enzymes as potential drug targets. However, the cellular functions and regulatory machineries of tankyrases are still largely unknown. Through this proteomic analysis, we not only defined the protein-protein interaction map for the tankyrases which revealed 100~150 high confident interacting proteins for tankyrases in various cellular functions, but also uncovered the novel regulating function of tankyrase in peroxisome homeostasis.

2017-07-24 | PXD004647 | Pride

Human proteome derivatized with iodoacetamide and acrylamide

Project description:This dataset was generated to parametrize and benchmark software for unbiased discovery of post-translationally modified peptides.

2021-07-22 | PXD019793 | Pride

Murine study of combined LPS and modified immunoglobulins associated gene expression changes in vivo

Project description:We systematically assessed the transcriptomic changes of lipopolysaccharides (LPS) of mice upon stimulation with immunoglobulins (IVIg), modified immunoglobulins (modIVIg) or vehicle controls in kidney, blood and liver in vivo. Data indicate different in vivo responses to LPS in conjunction with IVIg, modIVIg or vehicle. RNA from murine liver and kidney tissues (LPS+vehicle, LPS+IVIg, LPS+modIVIg; four samples each group) as well as circulating leukocytes from WBC (three samples each group) was extracted and subject to microarray analysis for comparison of transcriptomic responses. Normalization and quality control was performed for each organ separately.

2014-07-01 | E-GEOD-55694 | biostudies-arrayexpress

Sequential first-line therapy in metastatic colorectal cancer with Capecitabine/FUFA, Irinotecan and Bevacizumab

Project description:Primary objectives: Evaluation of effectiveness in correlation to tolerability of both therapy schemes in patients with metastatic colorectal cancer without Prior therapy. Primary endpoints: - Time to failure of treatment strategy (TFS) - If a comparable TFS is reached in both treatment arms, an analysis of the adverse effects should help to define the superior treatment strategy. Treatment related toxicity will be evaluated by analysis of all grade 2-5 toxicities divided by the number of administered treatment cycles within the TFS time intervall

| 2544319 | ecrin-mdr-crc

High-throughput proteomics identifies THEMIS2 as independent biomarker of inferior treatment-free survival in untreated chronic lymphocytic leukemia

Project description:Notwithstanding advances in the prognostication of chronic lymphocytic leukemia (CLL), it remains challenging to distinguish between patients with favorable and unfavorable treatment-free survival (TFS). Additionally, the downstream protein correlates of well-known molecular features of CLL are not always clear. To address this, we performed large-scale, unbiased characterization of global intracellular protein expression in a cohort of 40 CLL cases (patients with time to first treatment [TTFT] ≤24 months of sampling) and 40 age- and sex-matched CLL controls (patients with TTFT >24 months since sampling). Expression of 3268 proteins was quantified in the cohort. IGHV mutational status and trisomy 12 were most impactful on the CLL proteome. Intriguingly, comparing our results to three recently performed CLL mass-spectrometry screens, we identified four proteins that are strongly and consistently associated with IGHV mutational status: ZAP70, LMNA, FTL and FTH1. Additionally, we found that high intracellular protein levels of THEMIS2, a signaling protein acting downstream of the B-cell receptor, was significantly associated with short TTFT, independently of IGHV and TP53 mutational status (HR 2.47 [95%CI 1.54-3.95], P<0.01). This association was validated on the mRNA and protein level by qPCR and ELISA, respectivelly. Lastly, analysis of an independently generated CLL mass-spectrometry dataset verified the association between THEMIS2 expression and TFS (high THEMIS2, median TFS 4 months, versus low THEMIS2, median TFS not reached, P<0.0001)3. In conclusion, we present a comprehensive characterization of the proteome of untreated CLL. Of note, we identify elevated gene and protein expression of THEMIS2 as putative biomarker of inferior TTFT.

2023-10-24 | PXD036918 | Pride

Human Protein Tyrosine Phosphatase Interaction Network

Project description:As the remarkable prevalence of activated protein tyrosine kinases (TKs) as oncoproteins and their mutations being identified in numerous cancers, the control of protein tyrosine phosphorylation has been considered to play a central role in ensuring the homeostasis of cellular physiology and thus, preventing tumorigenesis. Protein tyrosine phosphatases (PTPs) can contribute to this equilibrium of protein tyrosine phosphorylation and thereby antagonize the oncogenic activities of tyrosine kinases, therefore, PTPs are prominently considered to act as tumor suppressors. To achieve a comprehensive understanding of the protein-protein interaction network for this PTP family, we isolated the ~ 70 PTP-associated protein complexes from HEK293T cells and provided a systematically proteomic analysis for this tumor suppressor family.

2016-08-17 | PXD002462 | Pride